The Dark Side of India's Pharma Industry: How You’re Being Fooled
The Indian government has recently imposed a ban on over 150 commonly used medicines, including widely consumed over-the-counter drugs such as Crocin, Cold and Flu Vicks, Action 500, and Dolo Cold. This decision affects countless households that rely on these medications for common ailments.
Role of Doctors in Prescriptions
India, with its vast population and limited scientific education, often sees people using drug combinations without proper understanding. This highlights the crucial role of doctors, who diagnose illnesses and guide patients on the appropriate use of medications, ensuring safety and effectiveness.
Pharmaceutical Companies and Market Manipulation
Many pharmaceutical companies, such as Microlabs, influence doctors to prescribe their branded medicines through unethical practices. These include offering expensive gifts and incentives, despite regulations prohibiting such endorsements. This practice leads to inflated medicine prices and compromises patient affordability. The Indian government has taken a strong stance against these manipulations, banning over 150 unnecessary and overpriced medicines to protect consumers.
National List of Essential Medicines (NLEM)
The National List of Essential Medicines (NLEM) identifies life-saving drugs that must be available within the healthcare system. To regulate prices and ensure affordability, the Indian government enforces pricing under the Drugs and Cosmetics Act of 1940 and the Essential Commodities Act of 1955. The current list consists of 384 drugs, categorized into 364 individual medicines and 20 Fixed-Dose Combinations (FDCs)—a category that has faced increased scrutiny.
Fixed-Dose Combination (FDC) Drugs and Their Ban
Fixed-Dose Combination (FDC) drugs, also known as cocktail drugs, are mixtures of two or more individual medications. While FDCs can be beneficial when formulated correctly, the government has banned certain combinations due to their potential health risks. Unlike single-component drugs like Paracetamol, these FDCs are often used by pharmaceutical companies to bypass pricing regulations on essential medicines, leading to irrational and sometimes harmful formulations.
Corruption in Drug Approvals
The Indian pharmaceutical industry is plagued by corruption and negligence, particularly in the drug approval process. Companies often find loopholes in regulatory frameworks, pushing untested and unsafe drugs into the market. A case study on a fictional company, GSF Pharma, and its new product, GSF Ultra, sheds light on the deep-rooted issues within the sector.
Regulatory Challenges in the Pharma Industry
To introduce a new medicine in India, pharmaceutical companies must secure approval from the Central Drugs Standard Control Organization (CDSCO) to verify the drug’s safety and efficacy. Additionally, they require a manufacturing license from the respective state licensing authority. However, corruption allows many companies to bypass these crucial steps, obtaining state-level licenses without proper verification. This results in the widespread circulation of unapproved and potentially harmful drugs in the market.
Conclusion
The ban on common medicines is a significant move by the Indian government to ensure safer healthcare practices and curb unethical pharmaceutical practices. While this decision may inconvenience consumers initially, it aims to protect public health by eliminating ineffective and overpriced medications. The crackdown on Fixed-Dose Combination drugs and corrupt drug approvals is a step towards a more transparent and patient-friendly pharmaceutical industry in India.
Consumers should always consult registered medical professionals before taking medications and be aware of the latest regulations regarding over-the-counter drugs.
Social Plugin